Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death

Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death Prostate Cancer and Prostatic Diseases advance online publication, November 8 2016. doi:10.1038/pcan.2016.53 Authors: N N Sanford, M-H Chen, M Loffredo, A Renshaw, P W Kantoff & A V D'Amico
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: Source Type: research